Cargando…
Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function
Nasolacrimal duct obstruction (NLDO) is thought to be due to inflammation and fibrosis of lacrimal duct epithelial cells (LDECs). Here we investigated the effect of rebamipide, a drug that is used for the protection of the mucosa and the treatment of gastritis and gastroduodenal ulcers, on LDECs, bo...
Autores principales: | Tanaka, Hiroshi, Nakayama, Tomomichi, Tsukamoto, Michiko, Watanabe, Akihide, Nakamura, Takahiro, Yokoi, Norihiko, Sotozono, Chie, Kinoshita, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997454/ https://www.ncbi.nlm.nih.gov/pubmed/32015381 http://dx.doi.org/10.1038/s41598-020-58314-x |
Ejemplares similares
-
Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013) -
A new surgical approach for punctal occlusion using fibrous tissue from under the lacrimal caruncle
por: Yokoi, Norihiko, et al.
Publicado: (2018) -
Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops
por: Ueta, Mayumi, et al.
Publicado: (2014) -
LRIG1 as a Potential Novel Marker for Neoplastic Transformation in Ocular Surface Squamous Neoplasia
por: Nagata, Maho, et al.
Publicado: (2014) -
Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity
por: Sotozono, Chie, et al.
Publicado: (2014)